These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 19924232
1. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM, Alcock L, Mestdagh P, Vandesompele J, Speleman F, London WB, McGrady PW, Higgins DG, O'Meara A, O'Sullivan M, Stallings RL. PLoS One; 2009 Nov 16; 4(11):e7850. PubMed ID: 19924232 [Abstract] [Full Text] [Related]
2. miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs. Terrile M, Bryan K, Vaughan L, Hallsworth A, Webber H, Chesler L, Stallings RL. PLoS One; 2011 Nov 16; 6(12):e28356. PubMed ID: 22164278 [Abstract] [Full Text] [Related]
6. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Vandesompele J, Edsjö A, De Preter K, Axelson H, Speleman F, Påhlman S. Oncogene; 2003 Jan 23; 22(3):456-60. PubMed ID: 12545167 [Abstract] [Full Text] [Related]
7. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C. Br J Cancer; 2011 Jul 12; 105(2):296-303. PubMed ID: 21654684 [Abstract] [Full Text] [Related]
8. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B. Int J Cancer; 2008 Feb 01; 122(3):699-704. PubMed ID: 17943719 [Abstract] [Full Text] [Related]
10. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Chen Y, Stallings RL. Cancer Res; 2007 Feb 01; 67(3):976-83. PubMed ID: 17283129 [Abstract] [Full Text] [Related]
12. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J. BMC Genomics; 2004 Sep 20; 5():70. PubMed ID: 15380028 [Abstract] [Full Text] [Related]
13. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Lovén J, Zinin N, Wahlström T, Müller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Påhlman S, Henriksson M. Proc Natl Acad Sci U S A; 2010 Jan 26; 107(4):1553-8. PubMed ID: 20080637 [Abstract] [Full Text] [Related]